Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Hoffmann-La Roche
Poitiers University Hospital
Washington University School of Medicine
Institut Cancerologie de l'Ouest
Institut de Cancérologie de Lorraine
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of California, San Francisco
Thomas Jefferson University
Centre Oscar Lambret
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Istituti Clinici Scientifici Maugeri SpA
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Poitiers University Hospital
Memorial Sloan Kettering Cancer Center
University Hospital Tuebingen
Memorial Sloan Kettering Cancer Center
Poitiers University Hospital
The Netherlands Cancer Institute
Istituti Clinici Scientifici Maugeri SpA
Assistance Publique - Hôpitaux de Paris
Austrian Breast & Colorectal Cancer Study Group
Memorial Sloan Kettering Cancer Center
University of Wisconsin, Madison
Centre Hospitalier Universitaire de Besancon
Lund University Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Institut Curie
Kansas State University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University of Chicago
Centre Georges Francois Leclerc
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University Medical Center Groningen
Mayo Clinic
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Memorial Sloan Kettering Cancer Center
University Hospital Augsburg
Assistance Publique Hopitaux De Marseille
Stanford University